期刊
CLINICAL CHEMISTRY
卷 56, 期 11, 页码 1701-1707出版社
AMER ASSOC CLINICAL CHEMISTRY
DOI: 10.1373/clinchem.2010.147256
关键词
-
资金
- National Natural Science Foundation of China [20635020]
- Creative Research Group [20821063]
- National Basic Research Program of China [2006CB933201]
- 863 Program of China [2007AA022001]
- General program [20875080]
BACKGROUND: The emergence of microfluidic immunosensors has provided a promising tool for improving clinical diagnoses. We developed an electrochemical immunoassay for the simultaneous detection of cardiac troponin I (cTnI) and C-reactive protein (CRP), based on microfluidic chips. METHODS: The quantitative methodology was based on ELISA in poly(dimethylsiloxane)-gold nanoparticle composite microreactors. CdTe and ZnSe quantum dots were bioconjugated with antibodies for sandwich immunoassay. After the CdTe and ZnSe quantum dots were dissolved, Cd2+ and Zn2+ were detected by square-wave anodic stripping voltammetry to enable the quantification of the 2 biomarkers. The 2 biomarkers were measured in 20 human serum samples by using the proposed method and commercially available methods. RESULTS: This immunosensor allowed simultaneous detection of serum cTnI and CRP. The linear range of this assay was between 0.01 and 50 mu g/L and 0.5 and 200 mu g/L, with the detection limits of approximately 5 amol and approximately 307 amol in 30-mu L samples corresponding to cTnI and CRP, respectively. Slopes close to 1 and the correlation coefficient over 0.99 were obtained for both analytes. CONCLUSIONS: This strategy demonstrates a proof of principle for the successful integration of microfluidics with electrochemistry that can potentially provide an alternative to protein detection in the clinical laboratory. (C) 2010 American Association for Clinical Chemistry
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据